Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Behiye Kodal"'
Autor:
Frank Cichocki, Jodie P. Goodridge, Ryan Bjordahl, Sajid Mahmood, Zachary B. Davis, Svetlana Gaidarova, Ramzey Abujarour, Brian Groff, Alec Witty, Hongbo Wang, Katie Tuininga, Behiye Kodal, Martin Felices, Greg Bonello, Janel Huffman, Thomas Dailey, Tom T. Lee, Bruce Walcheck, Bahram Valamehr, Jeffrey S. Miller
Publikováno v:
Blood. 140:2451-2462
Substantial numbers of B cell leukemia and lymphoma patients relapse due to antigen loss or heterogeneity after anti-CD19 chimeric antigen receptor (CAR) T cell therapy. To overcome antigen escape and address antigen heterogeneity, we engineered indu
Publikováno v:
Immuno; Volume 3; Issue 2; Pages: 237-249
Chemotherapy-refractive multiple myeloma (MM) is serious and life-threatening, and better treatments are urgently needed. BCMA is a prominent marker on the cell surface of MM cells, rendering it an accepted target for antibody therapy. Considering th
Autor:
Peter Hinderlie, Daniel J. Weisdorf, Martin Felices, Daniel A. Vallera, Veronika Bachanova, Sarah Cooley, Jeffrey S. Miller, Michael F. Kaminski, Behiye Kodal
Publikováno v:
Blood Advances. 3:897-907
Chronic lymphocytic leukemia (CLL) is characterized by chronic clonal expansion of mature CD19-expressing B lymphocytes and global dysfunction of immune effectors, including natural killer (NK) cells. CLL remains incurable, and novel approaches to re